Showing results (1041-1050 of 5,723) with videos related to

Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|November 1, 2018
Effects of extracellular acidity on resistance to chemotherapy treatment: a systematic reviewViviane Palmeira da Silva, Carulina Bueno Mesquita, Júlia Silveira Nunes, et al.
Medical Oncology (Northwood, London, England)|October 31, 2018
Autotaxin is a novel molecular identifier of type I endometrial cancerAntonio Mazzocca, Luca Maria Schönauer, Rosalba De Nola, et al.
Medical Oncology (Northwood, London, England)|April 2, 2017
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literatureIcro Meattini, Isacco Desideri, Giulio Francolini, et al.
Medical Oncology (Northwood, London, England)|April 3, 2017
Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapyNaoki Inui
Medical Oncology (Northwood, London, England)|November 15, 2018
Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemiaLuma Dayane de Carvalho Filiú-Braga, Teresa Raquel Tavares Serejo, Antonio Roberto Lucena-Araujo, et al.
Medical Oncology (Northwood, London, England)|November 15, 2018
Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapyMarkus Kieler, Matthias Unseld, Johann Wojta, et al.
Medical Oncology (Northwood, London, England)|July 26, 2019
Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysisAlexandra Giatromanolaki, Ioannis M Koukourakis, Konstantina Balaska, et al.
Medical Oncology (Northwood, London, England)|September 8, 2019
Outcomes in patients ≥ 80 years with a diagnosis of a hepatopancreaticobiliary (HPB) malignancyA R Lewis, C Cipriano, X Wang, et al.
Medical Oncology (Northwood, London, England)|September 8, 2019
Circulating CD16+CD56+ nature killer cells indicate the prognosis of colorectal cancer after initial chemotherapyFeng Cui, Di Qu, Ruya Sun, et al.
Medical Oncology (Northwood, London, England)|July 26, 2019
MPC-1 expression in myeloma cells is associated with the efficacy of bortezomib therapyKazuya Kurihara, Noriyoshi Iriyama, Katsuhiro Miura, et al.
Pageof 573